Presently research on dementia-Alzheimer's disease is facing a crucial paradox. This
enigma, which marks a critical turning point in the history of the field, is the result of …

This report brings together 21 of the global leading lights in all areas of dementia research.
Written by renowned journalist and broadcaster Christina Patterson (Time Magazine, The …

Alzheimer's Disease (AD) is the most common form of dementia, affecting approximately 36
million people worldwide. To date there is no preventive or curative treatment available for …

Although Alzheimer's disease (AD) was described nearly 100 years ago, systematic studies
focusing on the neurobiology of the disease have a relatively short history. The number of …

Alireza Atri mon Alzheimer's disease (AD) is the most comcause of neurodegenerative
dementia. In the next two to three decades, with changing demographics and longevity on …

The editors of Alzheimer's & Dementia announce the launch of a new Journal feature called
the “Special Topics Section”. The first special topic section will review and assess the current …

Although Alzheimer's disease, as a clinical-neuropathologic entity, was described 100 years
ago by Alois Alzheimer, the preponderance of knowledge about the disease has …

The 9th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy,
held in Geneva on April 19-22, 2006, brought together more than 750 basic and clinical …

Although significant accomplishments have been made in research to understand, diagnose
and treat Alzheimer's disease (AD) and its prequel, mild cognitive impairment, over the last …

In a decadeLs time, by 2030, the global prevalence of dementia will reach 75 million, with a
staggering cost of over 2 USD trillion worldwide [1]. The ambition to Lidentify a cure or a …